Feasibility of Using Economic Evaluation Evidence in Pharmaceutical Sector of the Iranian Health System: A Stakeholder Perspective
Background. Economic evaluation evidence can improve policies and decision-making processes in medicine and health system, prevent wastage of resources caused by trial and error, and facilitate the patients' access to medications. Therefore, the present study aimed to explore the feasibility of...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Tabriz University of Medical Sciences
2023-09-01
|
| Series: | Taṣvīr-i salāmat |
| Subjects: | |
| Online Access: | https://doh.tbzmed.ac.ir/PDF/doh-14-363.pdf |
| _version_ | 1797643427784949760 |
|---|---|
| author | Abolfazl Aliyari Shaghayegh Vahdat Soad Mahfoozpour Hossein Moshiri Tabrizi |
| author_facet | Abolfazl Aliyari Shaghayegh Vahdat Soad Mahfoozpour Hossein Moshiri Tabrizi |
| author_sort | Abolfazl Aliyari |
| collection | DOAJ |
| description | Background. Economic evaluation evidence can improve policies and decision-making processes in medicine and health system, prevent wastage of resources caused by trial and error, and facilitate the patients' access to medications. Therefore, the present study aimed to explore the feasibility of using economic evaluation evidence in the Iranian pharmaceutical sector. Methods. In this qualitative study, 29 stakeholders selected by purposeful sampling were interviewed using semi-structured interviews. The statistical population consisted of 29 experts in the fields of pharmacology, management, policymaking, and health economics. The inclusion criteria for participants included being employed in decision-making fields, having a minimum of a master's degree, as well as possessing sufficient and comprehensive knowledge of the subject matter. The interviews were analyzed adopting content analysis method, and the data were coded using the MAXQDA 11 software. Results. In order to identify the obstacles and facilitators of the application of economic evaluation evidence in medicine and health system, the study findings were extracted from three main sections (i.e., characteristics of production and extraction of evidence and information, mechanisms and requirements of using evidence, opportunities and benefits of using evidence) and 11 sub-sections of the identification. Conclusion. In sum, implementing all identified facilitators and mechanisms needed to establish a robust foundation was found extremely important for correcting an economic evaluation and evidence-based management. Removing the obstacles to an evidence-based management was also found crucial for creating an enabling environment required to implement the evidence-based practices effectively and for facilitating the production and utilization of evidence sources. |
| first_indexed | 2024-03-11T14:14:41Z |
| format | Article |
| id | doaj.art-dd10329b29b54e788e53d4c3a81b099a |
| institution | Directory Open Access Journal |
| issn | 2008-9058 2423-6640 |
| language | fas |
| last_indexed | 2024-03-11T14:14:41Z |
| publishDate | 2023-09-01 |
| publisher | Tabriz University of Medical Sciences |
| record_format | Article |
| series | Taṣvīr-i salāmat |
| spelling | doaj.art-dd10329b29b54e788e53d4c3a81b099a2023-11-01T09:10:20ZfasTabriz University of Medical SciencesTaṣvīr-i salāmat2008-90582423-66402023-09-0114336337710.34172/doh.2023.28doh-2966Feasibility of Using Economic Evaluation Evidence in Pharmaceutical Sector of the Iranian Health System: A Stakeholder PerspectiveAbolfazl Aliyari0Shaghayegh Vahdat1Soad Mahfoozpour2Hossein Moshiri Tabrizi3 Department of Health Services Management, Islamic Azad University, South Tehran Branch, Tehran, Iran Department of Health Services Management, Islamic Azad University, South Tehran Branch, Tehran, Iran Department of Health Services Management, Islamic Azad University, South Tehran Branch, Tehran, Iran Department of Health Services Management, Islamic Azad University, South Tehran Branch, Tehran, Iran Background. Economic evaluation evidence can improve policies and decision-making processes in medicine and health system, prevent wastage of resources caused by trial and error, and facilitate the patients' access to medications. Therefore, the present study aimed to explore the feasibility of using economic evaluation evidence in the Iranian pharmaceutical sector. Methods. In this qualitative study, 29 stakeholders selected by purposeful sampling were interviewed using semi-structured interviews. The statistical population consisted of 29 experts in the fields of pharmacology, management, policymaking, and health economics. The inclusion criteria for participants included being employed in decision-making fields, having a minimum of a master's degree, as well as possessing sufficient and comprehensive knowledge of the subject matter. The interviews were analyzed adopting content analysis method, and the data were coded using the MAXQDA 11 software. Results. In order to identify the obstacles and facilitators of the application of economic evaluation evidence in medicine and health system, the study findings were extracted from three main sections (i.e., characteristics of production and extraction of evidence and information, mechanisms and requirements of using evidence, opportunities and benefits of using evidence) and 11 sub-sections of the identification. Conclusion. In sum, implementing all identified facilitators and mechanisms needed to establish a robust foundation was found extremely important for correcting an economic evaluation and evidence-based management. Removing the obstacles to an evidence-based management was also found crucial for creating an enabling environment required to implement the evidence-based practices effectively and for facilitating the production and utilization of evidence sources.https://doh.tbzmed.ac.ir/PDF/doh-14-363.pdfeconomic evaluationevidence-based managementmedicinedecision makingpolicymaking |
| spellingShingle | Abolfazl Aliyari Shaghayegh Vahdat Soad Mahfoozpour Hossein Moshiri Tabrizi Feasibility of Using Economic Evaluation Evidence in Pharmaceutical Sector of the Iranian Health System: A Stakeholder Perspective Taṣvīr-i salāmat economic evaluation evidence-based management medicine decision making policymaking |
| title | Feasibility of Using Economic Evaluation Evidence in Pharmaceutical Sector of the Iranian Health System: A Stakeholder Perspective |
| title_full | Feasibility of Using Economic Evaluation Evidence in Pharmaceutical Sector of the Iranian Health System: A Stakeholder Perspective |
| title_fullStr | Feasibility of Using Economic Evaluation Evidence in Pharmaceutical Sector of the Iranian Health System: A Stakeholder Perspective |
| title_full_unstemmed | Feasibility of Using Economic Evaluation Evidence in Pharmaceutical Sector of the Iranian Health System: A Stakeholder Perspective |
| title_short | Feasibility of Using Economic Evaluation Evidence in Pharmaceutical Sector of the Iranian Health System: A Stakeholder Perspective |
| title_sort | feasibility of using economic evaluation evidence in pharmaceutical sector of the iranian health system a stakeholder perspective |
| topic | economic evaluation evidence-based management medicine decision making policymaking |
| url | https://doh.tbzmed.ac.ir/PDF/doh-14-363.pdf |
| work_keys_str_mv | AT abolfazlaliyari feasibilityofusingeconomicevaluationevidenceinpharmaceuticalsectoroftheiranianhealthsystemastakeholderperspective AT shaghayeghvahdat feasibilityofusingeconomicevaluationevidenceinpharmaceuticalsectoroftheiranianhealthsystemastakeholderperspective AT soadmahfoozpour feasibilityofusingeconomicevaluationevidenceinpharmaceuticalsectoroftheiranianhealthsystemastakeholderperspective AT hosseinmoshiritabrizi feasibilityofusingeconomicevaluationevidenceinpharmaceuticalsectoroftheiranianhealthsystemastakeholderperspective |